Treatment of Pemphigus Vulgaris with Rituximab and Intravenous Immune Globulin

R. Ahmed, A.; Spigelman, Zachary; A. Cavacini, Lisa; R. Posner, Marshall

doi:10.1056/nejmoa062930

Public

Treatment of Pemphigus Vulgaris with Rituximab and Intravenous Immune Globulin

Published in New England Journal of Medicine • Oct 25, 2006

Authors:

A. R. Ahmed

Zachary Spigelman

Lisa A. Cavacini

Abstract

BACKGROUND: Pemphigus vulgaris is a potentially fatal autoimmune mucocutaneous blistering disease. Conventional therapy consists of high-dose corticosteroids, immunosuppressive agents, and intravenous immune globulin. METHODS: We studied patients with refractory pemphigus vulgaris involving 30% or m...

Subject

Medicine

Rituximab

Pemphigus vulgaris

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!